Document:

Exhibit 10.2

 

Execution
Version

 

 

 

Trinity
Place Holdings Inc.

 

 

 

Warrant
Agreement

 

 

 

Dated as of December 19, 2019

 

Warrants
to Purchase Shares of Common Stock

 

 

 

 

This WARRANT AGREEMENT (this “Agreement”),
dated as of the date first written above, among Trinity Place Holdings Inc., a Delaware corporation (together with its successors
and assigns, the “Company”) and TPHS Lender LLC (together with its successors and assigns, the “Purchaser”).
Capitalized terms used herein but not otherwise defined shall have the meaning specified in Section 5.1 hereof.

 

RECITALS

 

WHEREAS, in accordance with the terms
of that certain Credit Agreement (as in effect from time to time, the “Credit Agreement”), dated as of the date
hereof, among the Company and the Purchaser and the other parties thereto, the Purchaser has agreed to acquire from the Company,
and the Company has agreed to issue to the Purchaser, a warrant to purchase, in the aggregate, 7,179,000 shares of the Company’s
Common Stock (“Common Stock”), par value $0.01 per share, currently tradable on the NYSE American stock exchange
under the ticker symbol “TPHS” (such initial warrant, together with any additional warrants issued pursuant to the
terms of this Agreement in connection with any partial or complete transfer or division of the initial warrant or any such additional
warrants, collectively, “Warrants”); and

 

WHEREAS, the Company and the Purchaser
wish to enter into this Agreement to govern the terms of the Warrants.

 

AGREEMENT

 

NOW, THEREFORE, in consideration
of the premises and the mutual agreements set forth herein, the parties to this Agreement hereby agree as follows:

 

1.            FORM,
EXECUTION AND TRANSFER OF WARRANT CERTIFICATES.

 

1.1           Form
of Warrant Certificates.

 

The Warrant Certificates shall be in the
form set forth in Annex 1 hereto. The Warrant Certificates may have such letters, numbers or other marks of identification
or designation as may be required to comply with any law or with any rule or regulation of any governmental authority, stock exchange
or self-regulatory organization made pursuant thereto (“Law”). Each Warrant Certificate shall be dated the
date of issuance thereof by the Company, either upon initial issuance or upon transfer or exchange. Each Warrant Certificate shall
represent the right to purchase the number of shares of Common Stock set forth in such Warrant Certificate at a price per share
of Common Stock equal to the Exercise Price; provided, that the number of shares of Common Stock issuable upon exercise
of the Warrants and the Exercise Price thereof shall be subject to adjustment as provided herein.

 

     

     

    

 

1.2           Execution
of Warrant Certificates; Registration Books.

 

(a)          Execution
of Warrant Certificates. The Warrant Certificates shall be executed on behalf of the Company by an officer of the Company authorized
by the Board of Directors. In case the officer of the Company who shall have signed any Warrant Certificate shall cease to be such
an officer of the Company before issuance and delivery by the Company of such Warrant Certificate, such Warrant Certificate nevertheless
may be issued and delivered with the same force and effect as though the individual who signed such Warrant Certificate had not
ceased to be such an officer of the Company, and any Warrant Certificate may be signed on behalf of the Company by any individual
who, at the actual date of the execution of such Warrant Certificate, shall be a proper officer of the Company to sign such Warrant
Certificate, although at the date of the execution of this Agreement any such individual was not such an officer.

 

(b)          Registration
Books. The Company will keep or cause to be kept at its office, maintained at the address of the Company referenced in Section
7.5, at the Company’s transfer agent, or at such other office of the Company of which the Company shall have given notice
to each holder of Warrant Certificates, books for registration and transfer of the Warrant Certificates issued hereunder. Such
books shall show the names and addresses of the respective holders of the Warrant Certificates, the registration number and date
of each of the Warrant Certificates and the Denomination thereof.

 

1.3           Transfer,
Split Up, Combination and Exchange of Warrant Certificates; Lost or Stolen Warrant Certificates.

 

(a)             Transfer,
Split Up, etc.

 

(i)          Transfer.
Subject to compliance with the Securities Act and any applicable state securities laws, any Warrant Certificate (or portion thereof)
may be transferred, with or without other Warrant Certificates, to any Person in exchange for a Warrant Certificate or Warrant
Certificates representing a right to purchase the number of shares of Common Stock, in the aggregate, which the holder of the surrendered
Warrant Certificate (or portion thereof) or Warrant Certificates shall have been entitled to purchase thereby. Any registered holder
desiring to transfer any Warrant Certificate shall make such request in writing delivered to the Company, which request shall include
the identity of the Transferee and the aggregate Denomination of Warrants to be transferred, and shall surrender the Warrant Certificate
or Warrant Certificates (or portions thereof) to be transferred at the office of the Company referenced in Section 7.5,
whereupon the Company shall deliver promptly to such Transferee a Warrant Certificate or Warrant Certificates, as the case may
be, as so requested, which Warrant Certificate or Warrant Certificates shall evidence, collectively, the same aggregate Denomination
of Warrants as the Warrant Certificate or Warrant Certificates (or portions thereof) so surrendered for transfer and shall issue
a new Warrant Certificate to the transferor representing the Warrants retained by the Transferor if such transfer involved less
than the entire Denomination of Warrants held by such Transferor. For the avoidance of doubt, subject only to compliance with the
procedural requirements set forth in this Agreement and with the requirements of applicable law, each Warrant Certificate shall
be freely transferable, in whole or in part, by the registered holder thereof without requiring any consent from or approval by
the Company or any other Person.

 

(ii)         Split
Up, Combination, Exchange, etc. Any Warrant Certificate, with or without other Warrant Certificates, may be split up, combined
or exchanged for another Warrant Certificate or Warrant Certificates, in an aggregate like Denomination as the Warrant Certificate
or Warrant Certificates surrendered then entitle such registered holder to purchase. Any registered holder desiring to split up,
combine or exchange any Warrant Certificate shall make such request in writing delivered to the Company, and shall surrender the
Warrant Certificate or Warrant Certificates to be split up, combined or exchanged at the office of the Company referenced in Section
7.5, whereupon the Company shall deliver promptly to such registered holder a Warrant Certificate or Warrant Certificates,
as the case may be, as so requested, which Warrant Certificate or Warrant Certificates shall evidence, collectively, the same aggregate
Denomination as the Warrant Certificate or Warrant Certificates so surrendered for split-up, combination or exchange.

 

    2

     

    

 

(b)             Loss,
Theft, etc. Upon receipt by the Company of evidence reasonably satisfactory to it of the ownership of, and the loss, theft,
destruction or mutilation of, any Warrant Certificate, and:

 

(i)          in
the case of loss, theft or destruction, an affidavit of loss, together with a customary and reasonable indemnity reasonably satisfactory
to the Company; or

 

(ii)         in
the case of mutilation, upon surrender and cancellation thereof;

 

the Company at its own expense will execute and deliver, in
lieu thereof, a new Warrant Certificate, dated the date of such lost, stolen, destroyed or mutilated Warrant Certificate and of
like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant Certificate and evidencing the same Denomination as the
Warrant Certificate so lost, stolen, destroyed or mutilated.

 

1.4           Subsequent
Issuance of Warrant Certificates.

 

Subsequent to the original issuance, no
Warrant Certificates shall be issued except:

 

(a)          Warrant
Certificates issued upon any transfer, combination, split up or exchange of Warrants pursuant to Section 1.3(a);

 

(b)          Warrant
Certificates issued in replacement of mutilated, destroyed, lost or stolen Warrant Certificates pursuant to Section 1.3(b);

 

(c)          Warrant
Certificates issued pursuant to Section 2.3 upon the partial exercise of any Warrant Certificate to evidence the unexercised
portion of such Warrant Certificate; and

 

(d)          Warrant
Certificates to reflect any adjustments pursuant to Section 4.

 

1.5           Effect
of Issuance in Registered Form.

 

Every holder of a Warrant Certificate by
accepting the same consents and agrees with the Company and with every other holder of a Warrant Certificate that:

 

(a)          the
Warrant Certificates are transferable only on the registry books of the Company if and when surrendered at the office of the Company
referenced in Section 7.5, duly endorsed or accompanied by an instrument of transfer (in the form attached thereto) and
payment of any applicable transfer, stamp or issue tax (a “Tax”); and

 

(b)          the
Company may deem and treat the Person in whose name each Warrant Certificate is registered as the absolute owner thereof and of
the Warrants evidenced thereby (notwithstanding any notations of ownership or writing on the Warrant Certificates made by anyone
other than the Company) for all purposes whatsoever, and the Company shall not be affected by any notice to the contrary.

 

2.            EXERCISE
OF WARRANTS; PAYMENT OF EXERCISE PRICE.

 

2.1           Exercise
of Warrants.

 

(a)          Manner
of Exercise. At any time and from time to time prior to the Expiration Time, the holder of any Warrant Certificate may exercise
the Warrants evidenced thereby, in whole or in any part, by surrender to the Company, at its office referenced in Section 7.5,
of such Warrant Certificate, together with a duly executed election to purchase (a form of which is attached to each Warrant Certificate)
and payment of the Exercise Price for each share of Common Stock with respect to which the Warrants are then being exercised and
an amount equal to any applicable Tax (if not payable by the Company as provided in Section 3.3). Such Exercise Price shall
be payable in cash or by withholding of shares of Common Stock into which the Warrants are being exercised pursuant to Section
2.1(b). Notwithstanding the foregoing or anything to the contrary herein, the exercise of Warrants shall be subject to Section
2.7 of this Agreement (Beneficial Ownership Limitation).

 

    3

     

    

 

(b)          Payment
in Cash or by Withholding of Common Stock. Upon exercise of any Warrants, the holder of a Warrant Certificate may pay the Exercise
Price by either (i) certified or official bank check payable to the order of the Company or by wire transfer of immediately available
funds to the account of the Company designated in writing by the Company or (ii) instructing the Company to withhold that number
of shares of Common Stock (or fraction thereof) then issuable upon such exercise with an aggregate Market Price as of such exercise
date equal to the aggregate Exercise Price. The Company acknowledges that the provisions of this clause are intended, in part,
to ensure that a full or partial exchange of a Warrant Certificate will qualify as a conversion, within the meaning of paragraph
(d)(3)(ii) of Rule 144 under the Securities Act.

 

(c)          Fractional
shares of Common Stock. The Company may, in accordance with Section 2.6, pay the exercising holder cash in lieu
of issuing a fractional share in connection with an exercise of Warrants; provided that, if it does not issue a fractional share
in such circumstances, it will make such cash payment.

 

2.2           Issuance
of Common Stock.

 

Upon timely receipt of a Warrant Certificate,
accompanied by the form of election to purchase duly executed, and payment of the Exercise Price for each of the shares of the
Common Stock to be purchased and by an amount equal to any applicable Tax (if not payable by the Company as provided in Section
3.3), the Company shall thereupon promptly cause certificates representing the number of whole shares of Common Stock then
being purchased, to be delivered to or upon the order of the holder of such Warrant Certificate, registered in such name or names
as may be designated by such holder, and, promptly after such receipt deliver the cash, if any, to be paid in lieu of fractional
shares pursuant to Section 2.6 to or upon the order of the holder of such Warrant Certificate.

 

2.3           Unexercised
Warrants.

 

In the event that the holder of any Warrant
Certificate shall exercise less than all the Warrants evidenced thereby, a new Warrant Certificate evidencing a Denomination equal
to the number of unexercised Warrants represented by such surrendered Warrant Certificate shall be issued by the Company to the
holder of such Warrant Certificate or to its duly authorized assigns.

 

2.4           Cancellation
and Destruction of Warrant Certificates.

 

All Warrant Certificates surrendered to
the Company for the purpose of exercise, payment of the Exercise Price, exchange, substitution or transfer shall be cancelled by
it, and no Warrant Certificates shall be issued in lieu thereof except as expressly permitted by any of the provisions of this
Agreement. The Company shall cancel and retire any other Warrant Certificates purchased or acquired by the Company.

 

2.5           Expiration.

 

All Warrants that have not been exercised
or purchased in accordance with the provisions of this Agreement shall expire and all rights of holders of such Warrants hereunder
shall terminate and cease at the Expiration Time.

 

2.6           Fractional
shares of Common Stock.

 

The Company shall not be required to issue
fractional shares of Common Stock upon the exercise of any Warrant. If fractional shares are not issued upon the exercise of any
Warrant, there shall be paid to the holder thereof, in lieu of any fractional share of Common Stock resulting therefrom, an amount
of cash equal to the product of: (a) the fractional amount of such share of Common Stock; and (b) the Market Price, as determined
on the trading day immediately prior to the date of exercise of such Warrant.

 

    4

     

    

 

2.7           Beneficial
Ownership Limitation.

 

(a)          Notwithstanding
anything to the contrary contained in this Agreement, the Company shall not effect the exercise of any portion of the Warrants,
and the Purchaser shall not have the right to exercise any portion of the Warrants, pursuant to the terms and conditions of the
Warrants, and any such exercise shall be null and void and treated as if never made, to the extent that after giving effect to
such exercise, the Purchaser together with the other Attribution Parties collectively would beneficially own in excess of 4.99%
(the “Maximum Percentage”) of the number of shares of Common Stock outstanding immediately after giving effect
to such exercise.

 

(b)          For
purposes of Section 2.7(a) of this Agreement, the aggregate number of shares of Common Stock which the Purchaser and the
other Attribution Parties “beneficially own” shall include the number of shares of Common Stock held by the
Purchaser and all other Attribution Parties plus the number of shares of Common Stock issuable upon exercise of the Warrants with
respect to which the determination of such Section 2.7(a) is being made, but shall exclude the number of shares of
Common Stock which would be issuable upon (1) exercise of the remaining, unexercised portion of the Warrants beneficially owned
by the Purchaser or any of the other Attribution Parties and (2) exercise or conversion of the unexercised or unconverted portion
of any other securities of the Company (including, without limitation, any convertible notes or convertible preferred stock or
warrants, including any other Warrants) beneficially owned by the Purchaser or any other Attribution Party subject to a limitation
on conversion or exercise analogous to the limitation contained in this Section 2.7. For purposes of this Section 2.7,
beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act, it being acknowledged that the
Company is not responsible for calculating the beneficial ownership of the Purchaser and its Attribution Parties or the number
or existence of Reduction Shares or Excess Shares, each as defined below. For purposes of this Agreement, in determining the number
of outstanding shares of Common Stock the Purchaser may acquire upon the exercise of a Warrant without exceeding the Maximum Percentage,
the Purchaser may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company’s most recent
Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the U.S.
Securities and Exchange Commission (“SEC”), as the case may be, (B) a more recent public announcement by the
Company or (C) any other written notice by the Company or the Company’s transfer agent setting forth the number of shares
of Common Stock outstanding (the “Reported Outstanding Share Number”). If the Company receives an Exercise
Notice from the Purchaser at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding
Share Number, the Company shall (x) notify the Purchaser in writing of the number of shares of Common Stock then outstanding and,
to the extent that such Exercise Notice would otherwise cause the Purchaser’s beneficial ownership, as determined pursuant
to this Section 2.7, to exceed the Maximum Percentage, the Purchaser shall notify the Company of a reduced number of Warrant
Shares to be purchased pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the “Reduction
Shares”) and (y) as soon as reasonably practicable, the Company shall return to the Purchaser any exercise price paid
by the Purchaser for the Reduction Shares. For any reason at any time, upon the written or oral request of the Purchaser, the
Company shall within one (1) Business Day confirm orally and by electronic mail to the Purchaser the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including such Warrant, by the Purchaser and any other Attribution
Party since the date as of which the Reported Outstanding Share Number was reported. In the event that the issuance of shares
of Common Stock to the Purchaser upon exercise of a Warrant results in the Purchaser and the other Attribution Parties being deemed
to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common Stock (as
determined under Section 13(d) of the Exchange Act), the Purchaser shall notify the Company of the number of shares so issued
by which the Purchaser’s and the other Attribution Parties’ aggregate beneficial ownership exceeds the Maximum Percentage
(the “Excess Shares”), the Excess Shares shall be deemed null and void and shall be cancelled ab initio,
and the Purchaser shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the
issuance of the Excess Shares has been deemed null and void, the Company shall return to the Purchaser the exercise price paid
by the Purchaser for the Excess Shares and a Warrant Certificate representing such Excess Shares. For purposes of clarity, the
shares of Common Stock issuable pursuant to the terms of a Warrant in excess of the Maximum Percentage shall not be deemed to
be beneficially owned by the Purchaser for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the Exchange
Act. No prior inability to exercise a Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 2.7 to the extent necessary
to correct this paragraph or any portion of this paragraph which may be defective or inconsistent with the intended beneficial
ownership limitation contained in this Section 2.7 or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor Transferee
of any Warrant.

 

    5

     

    

 

(c)          Notwithstanding
anything to the contrary contained in this Agreement, the Company shall not effect the exercise of any portion of the Warrants,
and the Purchaser shall not have the right to exercise any portion of the Warrants, pursuant to the terms and conditions of the
Warrants, and any such exercise shall be null and void and treated as if never made, to the extent that (1) such exercise would
result in the issuance of more than 19.9% of the shares of issued and outstanding Common Stock on the date hereof (prior to giving
effect to the issuance of Warrants under this Agreement) and (2) such issuance would require the vote of the holders of Common
Stock pursuant to the listing standards of any applicable Exchange (as defined below).

 

3.          AGREEMENTS
OF THE COMPANY.

 

3.1       Reservation
of Common Stock.

 

The Company covenants and agrees that at
all times such number of shares of Common Stock as will be sufficient to permit the exercise in full of all Warrants issued hereunder
into Common Stock shall be reserved and kept available out of its authorized and unissued shares of treasury shares of Common Stock.

 

3.2      Common
Stock to be Duly Authorized and Issued, Fully Paid and Nonassessable, etc.; Compliance with Law

 

The Company covenants and agrees that all
shares of Common Stock delivered upon the exercise of any Warrant and the payment of the Exercise Price pursuant to Section
2.1 (in each case, at the time of delivery of the certificates representing such shares of Common Stock) shall (a) be duly
and validly authorized and issued and fully paid and nonassessable, free of any preemptive rights in favor of any Person in respect
of such issuance and free of any security interest, pledge, mortgage, lien, charge or other encumbrance created by, or arising
out of actions of, the Company, in each case other than (i) resulting from the actions and circumstances of the holder of such
shares of Common Stock, (ii) to the extent imposed by applicable laws or (iii) in the Company’s organizational documents
and (b) be issued without violation of any applicable Law.

 

3.3      Taxes.

 

The Company covenants and agrees that it
will pay when due and payable any and all Taxes and charges that may be payable in respect of the initial issuance or delivery
of:

 

(a)          each
Warrant Certificate;

 

(b)          each
Warrant Certificate issued in exchange for any other Warrant Certificate pursuant to Section 1.3, Section 2.3 or
Section 4; and

 

(c)          each
share of Common Stock issued upon the exercise of any Warrant.

 

The Company shall not, however, be required
to:

 

(i)          pay
any Tax that may be payable in respect of the transfer or delivery of Warrant Certificates in a name other than that of the holder
of the Warrant Certificate surrendered for exercise, conversion, transfer or exchange (any such Tax being payable by the holder
of such certificate at the time of surrender);

 

(ii)       pay
any income or similar Tax payable upon the receipt, transfer, conversion or exchange of any Warrant Certificate or Warrant; or

 

    6

     

    

 

(iii)         issue
or deliver any such certificates referred to in the foregoing clauses (i) and (ii) until any such Tax referred to in the foregoing
clauses (i) and (ii) shall have been paid.

 

3.4       Common
Stock Ownership Record Date.

 

Each Person in whose name any certificate
for shares of Common Stock is issued upon the exercise of Warrants shall for all purposes be deemed to have become the holder of
record of the Common Stock represented thereby on, and such certificates (if any) shall be dated, the date upon which the Warrant
Certificate evidencing such Warrants was duly surrendered with an election to purchase attached thereto duly executed and payment
of the aggregate Exercise Price (and any applicable Taxes, if payable by such Person) was made.

 

3.5       Rights
in Respect of Common Stock.

 

Prior to the exercise of the Warrants evidenced
thereby, the holder of a Warrant Certificate shall not be entitled to any rights of a stockholder of the Company with respect to
the Common Stock into which the Warrants shall be exercisable, including, without limitation, the right to vote in respect of any
matter upon which the holders of Common Stock may vote, the right to receive any distributions of cash or property and, except
as expressly set forth herein, the right to receive any notice of any proceedings of the Company. Prior to the exercise of the
Warrants evidenced thereby, the holders of the Warrant Certificates shall not have as such any obligation in respect of any assessment
or any other obligation or liability as a stockholder of the Company, whether such obligations or liabilities are asserted by the
Company or by creditors of the Company.

 

4.          ANTI-DILUTION
ADJUSTMENTS.

 

4.1       Adjustments.

 

The number of shares of Common Stock purchasable
upon the exercise of each Warrant, and the Exercise Price, shall be subject to adjustment as set forth in this Section 4.

 

4.2       Stock Splits,
Subdivisions, Reclassifications or Combinations.

 

If the Company shall (i) declare and pay
a dividend or make a distribution on its Common Stock in shares of Common Stock, (ii) subdivide or reclassify the outstanding shares
of Common Stock into a greater number of shares, or (iii) combine or reclassify the outstanding shares of Common Stock into a smaller
number of shares, the Denomination of Common Stock issuable upon exercise of any Warrants at the time of the record date for such
dividend or effective date of such split, reverse split, subdivision, combination or reclassification shall be proportionately
adjusted so that the holder of such Warrants after such date shall be entitled to purchase the number of shares of Common Stock
which such holder would have owned or been entitled to receive in respect of the shares of Common Stock subject to such Warrants
after such date had such Warrants been exercised immediately prior to such date. In such event, the Exercise Price in effect at
the time of the effective date of such split, reverse split, subdivision, combination or reclassification shall be adjusted to
the number obtained by dividing (x) the product of (1) the Denomination before such adjustment and (2) the Exercise Price in effect
immediately prior to the record or effective date, as the case may be, for the dividend, distribution, split, reverse split, subdivision,
combination or reclassification giving rise to this adjustment by (y) the new number of shares of Common Stock issuable upon exercise
of such Warrants determined pursuant to the immediately preceding sentence; provided that the Exercise Price shall not be
adjusted to be less than the par value of the Common Stock.

 

4.3       Price-Based
Anti-Dilution

 

(a)          Without
duplication of the adjustments set forth in Sections 4.2 or 4.4, if the Company shall issue or sell any shares of
Common Stock (as actually issued or, pursuant to Section 4.3(b), deemed to be issued) for a consideration per share less
than the Market Price per share immediately prior to such issuance or sale, or if earlier, upon the execution of the definitive
documentation with respect to such issuance or sale (the “Effective Time”), then the Denomination of any Warrant
Certificate issuable upon exercise of any Warrants shall remain the same and immediately upon the Effective Time the Exercise
Price shall be decreased by dividing the Exercise Price by a fraction, (i) the numerator of which shall be the number of shares
of Common Stock actually outstanding immediately prior to the Effective Time plus the number of shares of Common Stock so issued
or sold, and (ii) the denominator of which shall be the number of shares of Common Stock actually outstanding immediately prior
to the Effective Time plus the number of shares of Common Stock which the aggregate consideration received by the Company for
the total number of shares of Common Stock so issued or sold would purchase if such shares were sold at the greater of the Market
Price or the Exercise Price. For the purposes of this Section 4.3(a), none of the following issuances shall be considered
the issuance or sale of Common Stock:

 

    7

     

    

 

(i)         the
issuance of Common Stock (i) upon the conversion or exercise of any then-outstanding Common Stock Equivalents, (ii) to Persons
in connection with joint ventures, strategic alliances, lending or other commercial relationships with such Person relating to
the operation of the Company’s business and not for the primary purpose of raising equity capital (including the potential
issuance of shares of Common Stock to the Company’s joint venture partner in connection with the acquisition of 250 North
10th Street, Williamsburg, Brooklyn (such joint venture, the “250 North 10th JV”)), in
connection with Business Combinations, or transactions in which the Company, directly or indirectly, acquires another business
or the assets thereof or (iii) in an offering for cash for the account of the Company that is either a rights offering made available
to all holders of the Common Stock or underwritten on a firm commitment basis and is registered with the SEC;

 

(ii)        the
issuance of any Common Stock or Common Stock Equivalents for which the adjustment provided in Section 4.2 applies upon exercise
of Warrants; or

 

(iii) the issuance of shares of Common Stock
or Common Stock Equivalents to employees or directors of either the Company or any Company subsidiary that is approved by, including
pursuant to a plan approved by, the Board of Directors.

 

(b)            For
the purposes of Section 4.3(a), the following subparagraphs (i) to (iii), inclusive, shall also be applicable:

 

(i)          If
the Company shall grant any rights to subscribe for, or any rights or options to purchase, Common Stock Equivalents, whether or
not such rights or options or the right to convert or exchange any such Common Stock Equivalents are immediately exercisable, and
the price per share for which Common Stock is issuable upon the exercise of such rights or options or upon conversion or exchange
of such Common Stock Equivalents (determined by dividing (A) the total amount, if any, received or receivable by the Company as
consideration for the granting of such rights or options, plus the minimum aggregate amount of additional consideration payable
to the Company upon the exercise of such rights or options, plus, in the case of any such rights or options which relate to such
Common Stock Equivalents, the minimum aggregate amount of additional consideration, if any, payable upon the issue or sale of such
Common Stock Equivalents and upon the conversion or exchange thereof, by (B) the total maximum number of shares of Common Stock
issuable upon the exercise of such rights or options or upon the conversion or exchange of all such Common Stock Equivalents issuable
upon the exercise of such rights or options) shall be less than the Market Price per share of Common Stock immediately prior to
the time of the granting of such rights or options, or, if earlier, the execution of definitive documentation with respect to such
grant, then the total maximum number of shares of Common Stock issuable upon the exercise of such rights or options or upon conversion
or exchange of the total maximum amount of such Common Stock Equivalents issuable upon the exercise of such rights or options shall
(as of the date of granting of such rights or options) be deemed to be outstanding and to have been issued for such price per share;
provided that no further adjustment of the conversion price pursuant to this Section 4.3(b)(i) shall be made (i) upon
the actual issuance or sale of such Common Stock Equivalents upon the exercise of any rights to subscribe for, or any rights or
options to purchase, such Common Stock Equivalents or (ii) upon the actual issuance or sale of such Common Stock upon the exercise
of any such Common Stock Equivalents, including without limitation, in each case of clauses (i) and (ii) with respect to shares
of Common Stock Equivalents or Common Stock issued or issuable as a result of the effect of antidilution adjustments under any
such security.

 

(ii)         If
the Company shall issue or sell any Common Stock Equivalents, whether or not the rights to exchange or convert thereunder are
immediately exercisable, and the price per share for which Common Stock is issuable upon such conversion or exchange (determined
by dividing (A) the total amount received or receivable by the Company as consideration for the issue or sale of such Common Stock
Equivalents, plus the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion
or exchange thereof, by (B) the total maximum number of shares of Common Stock issuable upon the conversion or exchange of all
such Common Stock Equivalents) shall be less than the Market Price per share of Common Stock immediately prior to the Effective
Time, then the total maximum number of shares of Common Stock issuable upon conversion or exchange of such Common Stock Equivalents
shall (as of the date of the issue or sale of such Common Stock Equivalents) be deemed to be outstanding and to have been issued
for such price per share, provided that no further adjustment of the conversion price pursuant to this Section 4.3(b)(ii)
shall be made upon the actual issuance or sale of such Common Stock upon the exercise of any such Common Stock Equivalents, including
without limitation, in each case with respect to shares of Common Stock issued or issuable as a result of the effect of antidilution
adjustments under any such security.

 

    8

     

    

 

(iii)        In
case at any time any shares of Common Stock or Common Stock Equivalents or any rights or options to purchase any such Common Stock
or Common Stock Equivalents shall be issued or sold for cash to a non-Affiliate of the Company (or to an Affiliate of the Company
in a transaction in which non-Affiliates of the Company also participated and led negotiations with respect to such transaction),
the consideration received therefor shall be deemed to be the amount received by the Company therefor. In case any shares of Common
Stock or Common Stock Equivalents or any rights or options to purchase any such Common Stock or Common Stock Equivalents shall
be issued or sold (x) to an Affiliate of the Company for cash in a transaction that does not meet the criteria of the preceding
sentence, or (y) for a consideration other than or in addition to cash, the Fair Market Value of the shares of Common Stock or
Common Stock Equivalents issued or sold by the Company (in the case of clause (y), to the extent the consideration received therefor
was other than cash), shall be deemed to be the amount received by the Company therefor.

 

4.4       Other
Distributions.

In case the Company shall (x) fix a record
date for the making of a dividend or distribution to holders of shares of its Common Stock of securities, evidences of indebtedness,
assets, cash, rights or warrants (excluding dividends of its Common Stock and other dividends or distributions referred to in Section
4.2) or (y) purchase any shares of its Common Stock above the Market Price per share of Common Stock (other than (i) purchases
from employees in connection with the payment of withholding taxes and (ii) dividends, distributions and purchases permitted by
the Credit Agreement), in each such case, the Exercise Price in effect prior to such record date shall be reduced by, as applicable,
(x) the amount of such dividend or distribution (which amount, in the case of a non-cash dividend or distribution, shall be the
Fair Market Value of the non-cash property which is the subject of such dividend or distribution) on a per share basis or (y) the
aggregate consideration for such purchased shares of Common Stock divided by the number of shares of Common Stock outstanding
immediately prior to giving effect to such purchase. In the event that any such dividend or distribution is not so made, the Exercise
Price and the Denomination then in effect shall be readjusted, effective as of the date when the Board of Directors determines
not to make such dividend or distribution, as the case may be, to the Exercise Price that would then be in effect and the number
of shares of Common Stock that would then be issuable upon exercise of such Warrants if such record date had not been fixed.

 

4.5       Change of Control.

 

Upon the occurrence of a Change of Control,
all Warrants then outstanding shall be automatically converted into the right to receive the difference between (x) that portion
of the consideration in the Change of Control that the holder would have received if the holder exercised the Warrant immediately
prior to such Change of Control and (y) the aggregate Exercise Price for such Warrant; provided, that if any portion of
any consideration received by the holders of Common Stock in connection with such Change of Control is not cash, each registered
holder of a Warrant at the time of such Change of Control shall have a right, in such registered holder’s sole discretion,
to instead receive an amount of cash equal to the Fair Market Value of any such non-cash consideration to which a holder of a number
of shares of Common Stock issuable upon exercise of such Warrant would otherwise be entitled; provided, that the Company
and the Required Warrantholders shall agree on reasonable procedures including notification to the holders of Warrants of an anticipated
Change of Control and of the election to receive cash, respectively. The Company shall not enter into or be party to any transaction
or agreement which would effect a Change of Control unless the successor of the Company (if any), assumes in writing the obligations
hereunder.

 

    9

     

    

 

4.6       Expiration
of Rights or Options.

 

Upon the expiration of any Common Stock
Equivalents or any rights or options to subscribe for, purchase or convert or exchange Common Stock or Common Stock Equivalents
in respect of the issuance, sale or grant of which adjustment was made pursuant to Section 4.3, without the exercise, subscription,
purchase conversion or exchange thereof, the Exercise Price shall, upon such expiration, be readjusted and shall thereafter be
such Exercise Price as would have been had such Exercise Price not been originally adjusted (or had the original adjustment not
been required, as the case may be), as if:

 

(a)          the
only shares of Common Stock so issued were the shares of Common Stock, if any, actually issued or sold upon the exercise of such
rights or options; and

 

(b)          such
shares of Common Stock, if any, were issued or sold for the consideration actually received by the Company upon such exercise,
subscription, purchase, conversion or exchange plus the aggregate consideration, if any, actually received by the Company for the
issuance, sale or grant of all of such rights or options, whether or not exercised.

 

4.7       Rounding
of Calculations; Minimum Adjustments.

 

All calculations under this Section 4
shall be made to the nearest one-tenth (1/10th) of a cent or to the nearest one-hundredth (1/100th) of a
share, as the case may be. Any provision of this Section 4 to the contrary notwithstanding, no adjustment in the Exercise
Price or the number of shares of Common Stock into which any Warrants are exercisable shall be made if the amount of such adjustment
would be less than $0.01 or one-tenth (1/10th) of a share of Common Stock, but any such amount shall be carried forward
and an adjustment with respect thereto shall be made at the earlier of (i) the time of any exercise of Warrants and (ii) the time
of and together with any subsequent adjustment which, together with such amount and any other amount or amounts so carried forward,
shall aggregate $0.01 or 1/10th of a share of Common Stock, or more.

 

4.8       Timing
of Issuance of Additional Common Stock Upon Certain Adjustments.

 

In any case in which the provisions of this
Section 4 shall require that an adjustment shall become effective immediately after a record date for an event, the Company
may defer until the occurrence of such event (i) issuing to the holder of any Warrants exercised after such record date and before
the occurrence of such event the additional shares of Common Stock issuable upon such exercise by reason of the adjustment required
by such event over and above the shares of Common Stock issuable upon such exercise before giving effect to such adjustment and
(ii) paying to such holder any amount of cash in lieu of a fractional share of Common Stock; provided, however, that
the Company upon written request of a holder shall deliver to such holder a due bill or other appropriate instrument evidencing
such holder’s right to receive such additional shares, and such cash, upon the occurrence of the event requiring such adjustment.

 

4.9       Miscellaneous.

 

(a)          Statement
Regarding Adjustments. Whenever the Exercise Price or the number of shares of Common Stock into which any Warrants are exercisable
shall be adjusted as provided in Section 4, the Company shall promptly file at the principal office of the Company referenced
in Section 7.5 a statement showing in reasonable detail the facts requiring such adjustment and the Exercise Price that
shall be in effect and the number of shares of Common Stock into which such Warrants shall be exercisable after such adjustment,
and the Company shall also cause a copy of such statement to be sent by mail, first class postage prepaid, or email to each holder
of Warrants at the address or email address appearing in the Company’s records.

 

    10

     

    

 

(b)          Notice
of Adjustment Event. In the event that the Board of Directors shall approve the taking by the Company of any action of the
type described in this Section 4 (but only if the action of the type described in this Section 4 would result in
an adjustment in the Exercise Price or the number of shares of Common Stock into which Warrants are exercisable or a change in
the type of securities or property to be delivered upon exercise of Warrants), the Company shall give notice to the holders of
Warrants, in the manner set forth in Section 4.9(a), which notice shall specify the record date, if any, with respect
to any such action and the approximate date on which such action is anticipated to take place. Such notice shall also set forth
the facts with respect thereto as shall be reasonably necessary to indicate the effect on the Exercise Price and the number, kind
or class of shares or other securities or property which shall be deliverable upon exercise of any Warrants. In the case of any
action which would require the fixing of a record date, such notice shall be given at least ten (10) business days prior to the
date so fixed (or otherwise in accordance with the notice requirements of the Exchange on which the Common Stock is listed), and
in case of all other action, such notice shall be given at least fifteen (15) business days prior to the taking of such proposed
action; provided, however, that the failure to give such notice, or any defect therein, shall not affect the legality or
validity of such event (but will, for the avoidance of doubt, constitute a breach of this Agreement). Without limiting the foregoing,
to the extent notice of any of the foregoing actions or events is given to the holders of the Common Stock, such notice shall
be provided to the holders of the Warrants on or before such notice to the holders of Common Stock (which such notice may be provided
to all such holders by a press release in accordance with Exchange rules).

 

(c)          
Proceedings Prior to Any Action Requiring Adjustment. As a condition precedent to the taking of any action which would require
an adjustment pursuant to this Section 4, the Company shall use reasonable best efforts to take any action which may be
necessary, including obtaining regulatory, NYSE American, New York Stock Exchange, NASDAQ Stock Market or other applicable national
securities exchange (an “Exchange”) or stockholder approvals or exemptions, in order that the Company may
thereafter validly and legally issue as fully paid and nonassessable all shares of Common Stock that the holders are entitled to
receive upon exercise of this any Warrants pursuant to this Section 4.

 

(d)          Adjustment
Rules. Any adjustments pursuant to this Section 4 shall be made successively whenever an event referred to herein shall
occur. If more than one subsection of this Section 4 is applicable to a single event, the subsection shall be applied that
produces the largest adjustment and no single event shall cause an adjustment under more than one subsection of this Section
4 so as to result in duplication. If an adjustment in Exercise Price made hereunder would reduce the Exercise Price to an amount
below par value of the Common Stock, then such adjustment in Exercise Price made hereunder shall reduce the Exercise Price to the
par value of the Common Stock.

 

5.            INTERPRETATION
OF THIS AGREEMENT.

 

5.1       Certain
Defined Terms.

 

For the purpose of this Agreement, the following
terms shall have the meanings set forth below or set forth in the Section hereof following such term:

 

“Affiliate” shall have
the meaning ascribed to such term in Rule 405 of the Securities Act; provided, however, that the Purchaser shall not be
deemed to be an “Affiliate” of the Company and no Person holding any one or more of the Warrants shall be deemed to
be an “Affiliate” of the Company solely by virtue of the ownership thereof.

 

“Attribution Parties”
means, collectively, the following Persons (which Persons will, together with the Purchaser, for the avoidance of doubt, collectively
be subject to the Maximum Percentage): (i) any investment vehicle, including, any funds, feeder funds or managed accounts, currently,
or from time to time after the Issue Date, directly or indirectly managed or advised by the Purchaser’s investment manager
or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Purchaser or any of the foregoing, (iii)
any Person acting or who could be deemed to be acting as a Group together with the Purchaser or any of the foregoing and (iv) any
other Persons whose beneficial ownership of the Common Stock would or could be aggregated with the Purchaser’s and the other
Attribution Parties for purposes of Section 13(d) of the Exchange Act.

 

“Board of Directors”
means the board of directors of the Company, including any duly authorized committee thereof.

 

“business day” means
any day other than Saturday, Sunday or other day on which commercial banks in the City of New York, New York are authorized or
required by Law to remain closed.

 

    11

     

    

 

“Change of Control” means
the occurrence of any of the following: (a) the sale, transfer or conveyance, in one or more related transactions, of all or substantially
all of the assets of the Company and its subsidiaries on a consolidated basis; (b) any Person or two or more Persons acting
in concert shall have acquired and shall continue to have following the date hereof, beneficial ownership (within the meaning of
Rule 13d-3 of the SEC under the Exchange Act), directly or indirectly, of Voting Interests (as defined in the Credit Agreement)
of the Company (or other securities convertible at such time into such Voting Interests) representing 50% or more of the combined
voting power of all Voting Interests of the Company; or (c) the adoption of any plan relating to the Company’s dissolution
or liquidation.

 

“Common Stock Equivalents”
means all options, derivatives, rights, warrants and convertible, exercisable or exchangeable securities or instruments (including,
without limitation, awards or grants of such securities or instruments to directors, officers, employees or consultants of the
Company or to other persons), in each case, that are convertible into, or exercisable or exchangeable for, or otherwise derive
their value from, (a) shares of Common Stock or (b) other equity securities which grant any person voting powers or preferences
or economic or political rights comparable to those associated with shares of Common Stock.

 

“Denomination” means,
in the case of any Warrant Certificate, the number of shares of Common Stock issuable upon exercise of such Warrant Certificate.

 

“Exchange” shall have
the meaning set forth in Section 4.9(c).

 

“Exchange Act” means
the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder.

 

“Exercise Price” means,
prior to any adjustment pursuant to Section 4 of this Agreement, the Initial Exercise Price; and thereafter, the Initial
Exercise Price as successively adjusted and readjusted from time to time in accordance with the provisions of Section 4.

 

“Expiration Time” means
5:00 p.m., Eastern time, on the tenth (10th) year anniversary of the date hereof.

 

“Fair Market Value” means,
with respect to any security or other property, the fair market value of such security or other property as determined by the Board
of Directors, acting in good faith and transmitted to the holders of Warrants by written notice. The Required Warrantholders may
object in good faith in writing to the Board of Director’s calculation of Fair Market Value within ten (10) business days
of receipt of such written notice thereof, setting forth the basis of such objection in reasonable detail. If the Required Warrantholders
and the Board of Directors are unable to agree on Fair Market Value during the 10-business-day period following the delivery
of the Required Warrantholders’ objection, then the Board of Directors shall, at the Company’s sole cost and expense,
select and approve an appraiser of national recognition experienced in the business of evaluating or appraising the market value
of securities or other property (which appraiser shall be subject to approval by the Required Warrantholders, which approval shall
not be unreasonably withheld, conditioned or delayed). The Fair Market Value established by such appraiser shall be conclusive
and binding on the parties.

 

“Group” means a “group”
as that term is used in Section 13(d) of the Exchange Act and as defined in Rule 13d-5 thereunder.

 

“Initial Exercise Price”
means $6.50.

 

“Issue Date” means the
date of this Agreement.

 

    12

     

    

 

“Market Price” means
(a) with respect to shares of Common Stock, on any given day, the volume-weighted average price per share of such Common Stock
on the NYSE American stock exchange for the ten (10) trading days ending on the trading date immediately prior to such day, as
reported by Bloomberg (the “VWAP”), or, if the VWAP is not available, the last reported sale price or, in case
no such reported sale takes place on such day, the average of the last closing bid and ask prices, in either case on the NYSE
American stock exchange, and (b) with respect to a particular security other than shares of Common Stock, on any given day, the
last reported sale price or, in case no such reported sale takes place on such day, the average of the last closing bid and ask
prices, in either case on the Exchange on which the applicable securities are listed or admitted to trading. “Market
Price” shall be determined without reference to after hours or extended hours trading. If such security is not listed
and traded in a manner that the quotations referred to above are available for the period required hereunder, the Market Price
per share of Common Stock shall be deemed to be the fair market value per share of such security as determined in good faith by
the Board of Directors; provided that the Required Warrantholders may object in good faith in writing to the Board of Director’s
calculation of fair market value within ten (10) business days of receipt of written notice thereof, setting forth the basis of
such objection in reasonable detail. If the Required Warrantholders and the Board of Directors are unable to agree on fair market
value during the 10-business-day period following the delivery of the Required Warrantholders’ objection, then the Board
of Directors shall, at the Company’s sole cost and expense, select and approve a nationally recognized independent investment
banking corporation retained by the Company for valuation purposes (the “appraiser”), which appraiser shall
be subject to approval by the Required Warrantholders, not to be unreasonably withheld, conditioned or delayed. The Market Price
established by such appraiser shall be conclusive and binding on the parties. For the purposes of determining the Market Price
of the Common Stock on the “trading day” preceding, on or following the occurrence of an event, (i) that trading
day shall be deemed to commence immediately after the regular scheduled closing time of trading on the NYSE American stock exchange
or, if trading is closed at an earlier time, such earlier time and (ii) that trading day shall end at the next regular scheduled
closing time, or if trading is closed at an earlier time, such earlier time (for the avoidance of doubt, and as an example, if
the Market Price is to be determined as of the last trading day preceding a specified event and the closing time of trading on
a particular day is 4:00 p.m. and the specified event occurs at 5:00 p.m. on that day, the Market Price would be determined by
reference to such 4:00 p.m. closing price).

  

“Person” means an individual,
a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other
entity and a government or any department or agency thereof.

 

“Required Warrantholders”
means, at any time, the holders of Warrants representing at least a majority of the Common Stock issuable upon exercise of the
Warrants issued hereunder and not previously exercised (exclusive of any Warrants directly or indirectly held by the Company or
any Affiliate of the Company).

 

“Securities Act” means
the Securities Act of 1933, as amended, or any successor statute, and the rules and regulations promulgated thereunder.

 

“trading day” means (A)
if the shares of Common Stock are not traded on any national or regional securities exchange or association or over-the-counter
market, a business day or (B) if the shares of Common Stock are traded on any national or regional securities exchange or association
or over-the-counter market, a business day on which such relevant exchange or over-the-counter quotation system is scheduled to
be open for business and on which the shares of Common Stock (i) are not suspended from trading on any national or regional securities
exchange or association or over-the-counter market for any period or periods aggregating one half hour or longer; and (ii) have
traded at least once on the national or regional securities exchange or association or over-the-counter market that is the primary
market for the trading of the shares of Common Stock.

 

“Transferee” means any
registered transferee of all or any part of any one or more Warrant Certificates initially acquired by the Purchaser under this
Agreement.

 

“Warrant” means a warrant
to purchase shares of Common Stock issued pursuant to this Agreement.

 

“Warrant Certificate”
means a certificate evidencing the Warrants in the form of Annex 1.

 

5.2       Section
Heading and Table of Contents and Construction.

 

(a)          Section
Headings and Table of Contents, etc. The titles of the Sections of this Agreement and any Table of Contents of this Agreement
appear as a matter of convenience only, do not constitute a part hereof and shall not affect the construction hereof. The words
“herein,” “hereof,” “hereunder” and “hereto” refer to this Agreement as a whole
and not to any particular Section or other subdivision. References to Sections are, unless otherwise specified, references to Sections
of this Agreement. References to Annexes are, unless otherwise specified, references to Annexes attached to this Agreement.

 

    13

     

    

 

(b)          Independent
Construction. Each covenant contained herein shall be construed (absent an express contrary provision herein) as being independent
of each other covenant contained herein, and compliance with any one covenant shall not (absent such an express contrary provision)
be deemed to excuse compliance with one or more other covenants.

 

5.3       Directly
or Indirectly.

 

Where any provision herein refers to action
to be taken by any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action
is taken directly or indirectly by such Person, including actions taken by or on behalf of any partnership in which such Person
is a general partner.

 

5.4       Governing
Law.

 

THIS AGREEMENT AND THE WARRANT CERTIFICATES
SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE PARTIES SHALL BE GOVERNED BY, THE INTERNAL LAWS OF THE
STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS RULES THEREOF TO THE EXTENT THAT ANY SUCH RULES WOULD REQUIRE
OR PERMIT THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION, EXCEPT TO THE EXTENT THAT THE DELAWARE GENERAL CORPORATION LAW
SPECIFICALLY AND MANDATORILY APPLIES.

    

6.            ADDITIONAL
RIGHTS OF REGISTERED HOLDERS OF WARRANTS.

 

6.1      Registration
Rights.

 

Concurrently with the execution of this
Agreement, the parties hereto are entering into that certain registration rights agreement (the “RRA”). Any
Transferee shall execute a joinder to the RRA at the time of the applicable transfer.

 

6.2       Confidential
Information.

 

Notwithstanding anything to the contrary
contained in this Agreement, to the extent that any notice to be provided to registered holders of Warrants pursuant to this Agreement
constitutes, or contains, material, non-public information regarding the Company and the Company would be required to disclose
such information under Regulation FD of the SEC or other applicable Law, such notice shall instead be delivered only to registered
holders of Warrants who are the Purchaser or Affiliates of the Purchaser or other holders that have elected to receive such information,
in each case who are subject to a nondisclosure agreement consistent with the requirements of Regulation FD of the SEC.

 

7.            MISCELLANEOUS.

 

7.1       Expenses.

 

Issuance of certificates for shares of Common
Stock to a holder upon the exercise of any Warrants shall be made without charge to such holder for any Tax or stamp duty in respect
of the issuance of such certificates, all of which Taxes and stamp duties shall be paid by the Company (for the avoidance of doubt,
specifically excluding the Taxes not payable by the Company pursuant to Section 3.3).

 

7.2       Amendment
and Waiver.

 

This Agreement may be amended, and the
observance of any term of this Agreement may be waived, with and only with the written consent of the Company and the Purchaser;
provided, however, that (a) no amendment or waiver of the rights, preferences or privileges of the Warrants may be made
without the prior written consent of the Required Warrantholders, and (b) no such amendment or waiver of any of the provisions
of this Agreement pertaining to the Exercise Price or the number of shares or kind of Common Stock that may be purchased upon
exercise of each Warrant and no such amendment accelerating the occurrence of the Expiration Time shall be effective as to a holder
of Warrants unless consented to in writing by such holder.

 

    14

     

    

 

7.3       Entire
Agreement.

 

This Agreement and the Warrant Certificates,
together with the RRA, the Credit Agreement and that certain Letter Agreement, dated as of the date hereof, between the Company
and the Purchaser, embody the entire agreement and understanding among the Company and the Purchaser with respect to the Warrants,
and supersede all prior agreements and understandings, relating to the subject matter hereof.

 

7.4        Successors
and Assigns; Multiple Holders.

 

All covenants and other agreements in this
Agreement made by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and
assigns of the parties hereto to the extent they become holders of Warrants (including, without limitation, any Transferee) whether
so expressed or not. Notwithstanding the foregoing sentence, the Company may not assign any of its rights, duties or obligations
hereunder or under the Warrant Certificates except pursuant to the terms of this Agreement without the prior written consent of
the Required Warrantholders.

 

Each holder of a Warrant agrees that (i)
no other holder of a Warrant will by virtue of this Warrant or exercise thereof be under any fiduciary or other duty to give or
withhold any consent or approval under this Warrant or to take any other action or omit to take any action under this Warrant and
(ii) each other holder of a Warrant may act or refrain from acting under this Warrant as such other holder may, in its discretion,
elect.

 

7.5       Notices
and Information.

 

All communications hereunder or under the
Warrants shall be in writing and shall be delivered either by certified or registered mail, postage pre-paid, return receipt requested,
email, facsimile or nationally recognized overnight courier, and shall be addressed to the following addresses:

 

(a)          if
to the Purchaser, at its address set forth on Annex 2-A to this Agreement, or at such other address as such Purchaser shall
have specified to the Company in writing;

 

(b)          if
to any other holder of any Warrant Certificate, addressed to such other holder at such address as such other holder shall have
specified to the Company in writing or, if any such other holder shall not have so specified an address to the Company, then addressed
to such other holder in care of the last holder of such Warrant Certificate that shall have so specified an address to the Company;
and

 

(c)          if
to the Company, at the address set forth on Annex 2-B to this Agreement, or at such other address as the Company shall have
specified to each holder of Warrants in writing.

 

Any communication addressed and delivered
as herein provided shall be deemed to be received when actually delivered to the address of the addressee (whether or not delivery
is accepted) by (i) a nationally recognized overnight delivery service which provides proof of delivery or three (3) Business Days
after the date on which postmarked if sent by registered or certified mail or (ii) upon receipt by the recipient’s facsimile
system or email server ((A) if received before the opening of business on a Business Day or received during business hours on a
Business Day, receipt shall be deemed to have occurred on such date and (B) if received after the close of business hours or on
any day that is not a Business Day, receipt shall be deemed to have occurred on the next succeeding Business Day) if directed to
the facsimile number or email address provided in the notice section hereof, as the case may be. Any communication not so addressed
and delivered shall be ineffective unless actually received by the intended addressee as provided above. Notwithstanding the foregoing
provisions of this Section 7.5, service of process in any suit, action or proceeding arising out of or relating to this
Agreement or any document, agreement or transaction contemplated hereby shall be delivered in the manner provided in Section
7.8(c).

 

    15

     

    

 

7.6       Severability.

 

Any provision of this Agreement that is
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition
or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction
shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

7.7       Execution
in Counterparts.

 

This Agreement may be executed in one or
more counterparts and shall be effective when at least one counterpart shall have been executed by each party hereto, and each
set of counterparts that, collectively, show execution by each party hereto shall constitute one duplicate original.

 

7.8       Waiver
of Jury Trial; Consent to Jurisdiction, Etc.

 

(a)          Waiver
of Jury Trial. THE PARTIES HERETO VOLUNTARILY AND INTENTIONALLY WAIVE ANY RIGHT ANY OF THEM MAY HAVE TO A TRIAL BY JURY IN
RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE WARRANTS OR ANY OF THE DOCUMENTS, AGREEMENTS
OR TRANSACTIONS CONTEMPLATED HEREBY.

 

(b)          Consent
to Jurisdiction. ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE WARRANTS, OR ANY OF THE
DOCUMENTS, AGREEMENTS OR TRANSACTIONS CONTEMPLATED HEREBY (WHETHER IN TORT, CONTRACT OR OTHERWISE) OR ANY ACTION OR PROCEEDING
TO EXECUTE OR OTHERWISE ENFORCE ANY JUDGMENT IN RESPECT OF ANY BREACH UNDER THIS AGREEMENT, THE WARRANTS OR ANY DOCUMENT OR AGREEMENT
CONTEMPLATED HEREBY SHALL BE BROUGHT BY SUCH PARTY IN ANY NEW YORK STATE COURT OR FEDERAL DISTRICT COURT LOCATED IN THE SOUTHERN
DISTRICT OF NEW YORK AS SUCH PARTY MAY IN ITS SOLE DISCRETION ELECT, AND BY THE EXECUTION AND DELIVERY OF THIS AGREEMENT, THE PARTIES
HERETO IRREVOCABLY AND UNCONDITIONALLY SUBMIT TO THE IN PERSONAM JURISDICTION OF EACH SUCH COURT, AND EACH OF THE PARTIES HERETO
IRREVOCABLY WAIVES AND AGREES NOT TO ASSERT IN ANY PROCEEDING BEFORE ANY TRIBUNAL, BY WAY OF MOTION, AS A DEFENSE OR OTHERWISE,
ANY CLAIM THAT IT IS NOT SUBJECT TO THE IN PERSONAM JURISDICTION OF ANY SUCH COURT. IN ADDITION, EACH OF THE PARTIES HERETO IRREVOCABLY
WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE IN ANY SUIT,
ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY DOCUMENT, AGREEMENT OR TRANSACTION CONTEMPLATED HEREBY
BROUGHT IN ANY SUCH COURT, AND HEREBY IRREVOCABLY WAIVES ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH
COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.

 

(c)          Service
of Process. EACH PARTY HERETO IRREVOCABLY AGREES THAT PROCESS PERSONALLY SERVED OR SERVED BY U.S. REGISTERED MAIL AT THE ADDRESSES
PROVIDED HEREIN FOR NOTICES SHALL CONSTITUTE, TO THE EXTENT PERMITTED BY LAW, ADEQUATE SERVICE OF PROCESS IN ANY SUIT, ACTION OR
PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE WARRANTS OR ANY DOCUMENT, AGREEMENT OR TRANSACTION CONTEMPLATED HEREBY,
OR ANY ACTION OR PROCEEDING TO EXECUTE OR OTHERWISE ENFORCE ANY JUDGMENT IN RESPECT OF ANY BREACH HEREUNDER, UNDER THE WARRANTS
OR UNDER ANY DOCUMENT OR AGREEMENT CONTEMPLATED HEREBY. RECEIPT OF PROCESS SO SERVED SHALL BE CONCLUSIVELY PRESUMED AS EVIDENCED
BY A DELIVERY RECEIPT FURNISHED BY THE UNITED STATES POSTAL SERVICE OR ANY COMMERCIAL DELIVERY SERVICE.

 

[Remainder of page intentionally left
blank; signature page follows]

 

    16

     

    

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement on the date first above written.

 

	 	COMPANY:
	 	 
	 	TRINITY PLACE HOLDINGS INC.
	 	 
	 	By:   	/s/
    Steven Kahn
	 	Name: Steven Kahn
	 	Title:
    Chief Financial Officer
	 	 
	 	 
	 	PURCHASER:
	 	 
	 	TPHS Lender LLC
	 	 
	 	By: 	Midtown Acquisitions GP LLC, its Manager
	 	 
	 	By:	 /s/ Joshua D. Morris
	 	Name: Joshua D. Morris
	 	Title: Manager

 

[Signature Page
to Warrant Agreement]

 

    

     

    

 

ANNEX 1

 

[FORM OF WARRANT CERTIFICATE]

 

THE SECURITIES REPRESENTED HEREBY, AND THE SECURITIES ISSUABLE
HEREBY, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES
NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL
FOR THE COMPANY, IS AVAILABLE. THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO THE TERMS OF THAT CERTAIN WARRANT
AGREEMENT, DATED AS OF DECEMBER 19, 2019, THE PROVISIONS OF WHICH ARE INCORPORATED HEREIN BY REFERENCE. A COPY OF SUCH AGREEMENT
IS AVAILABLE FROM THE COMPANY UPON REQUEST.

 

WARRANT CERTIFICATE

 

Trinity
Place Holdings Inc.

 

Date: ______________, 2019

 

This Warrant Certificate certifies that
____________________________, or its registered assigns, is the registered holder of Warrants entitling the owner thereof to purchase
at any time on or after the date hereof and on or prior to the Expiration Time, ______________ fully paid and nonassessable shares
of Common Stock, par value $0.01 per share (the “Common Stock”), of Trinity
Place Holdings Inc., a Delaware corporation (together with its successors and assigns, the “Company”),
at a purchase price (subject to adjustment as provided in the Warrant Agreement (as defined below), the “Exercise Price”)
of $6.50 per share of Common Stock upon presentation and surrender of this Warrant Certificate to the Company with a duly executed
election to purchase and payment of the Exercise Price (including by withholding of shares of Common Stock), all in the manner
set forth in the Warrant Agreement (as defined below). The Denomination of each Warrant and the Exercise Price are the Denomination
and the Exercise Price as of the date hereof, and are subject to adjustment as referred to below.

 

The Warrants are issued pursuant to a Warrant
Agreement (as it may from time to time be amended or supplemented, the “Warrant Agreement”), dated as of December
19, 2019, among the Company and TPHS Lender LLC, and are subject to all of the terms, provisions and conditions thereof, which
Warrant Agreement is hereby incorporated herein by reference and made a part hereof and to which Warrant Agreement reference is
hereby made for a full description of the rights, obligations, duties and immunities of the Company and the holders of the Warrant
Certificates. Capitalized terms used, but not defined, herein have the respective meanings ascribed to them in the Warrant Agreement.
In the event of any conflict between this Warrant Certificate and the Warrant Agreement, the Warrant Agreement shall control and
govern.

 

As provided in the Warrant Agreement, the
Exercise Price and the Denomination evidenced by this Warrant Certificate are, upon the happening of certain events, subject to
modification and adjustment. Except as otherwise set forth in, and subject to, the Warrant Agreement, the Expiration Time of this
Warrant Certificate is as set forth in the Warrant Agreement.

 

Subject to the limitations set forth in
the Warrant Agreement, this Warrant Certificate shall be exercisable, at the election of the holder, at any time on or after the
date hereof and on or prior to the Expiration Time either as an entirety or in part from time to time. If this Warrant Certificate
shall be exercised in part, the holder shall be entitled to receive, upon surrender hereof, another Warrant Certificate or Warrant
Certificates for the Denomination not exercised. This Warrant Certificate, with or without other Warrant Certificates, upon surrender
in the manner set forth in the Warrant Agreement and subject to the conditions set forth in the Warrant Agreement, may be transferred
or exchanged for another Warrant Certificate or Warrant Certificates of like tenor evidencing Warrants entitling the holder to
a like Denomination as the Warrants evidenced by the Warrant Certificate or Warrant Certificates surrendered shall have entitled
such holder to purchase.

 

    

     

    

 

No holder of this Warrant Certificate shall
be entitled to vote or receive distributions or be deemed for any purpose the holder of shares of Common Stock or of any other
Securities of the Company that may at any time be issued upon the exercise hereof, nor shall anything contained in the Warrant
Agreement or herein be construed to confer upon the holder hereof, as such, any of the rights of a holder of a share of Common
Stock in the Company or any right to vote upon any matter submitted to holders of shares of Common Stock at any meeting thereof,
or to give or withhold consent to any corporate action of the Company (whether upon any recapitalization, issuance of stock, reclassification
of Securities, change of par value, consolidation, merger, conveyance, or otherwise), or to receive dividends or subscription rights,
or otherwise, until the Warrant or Warrants evidenced by this Warrant Certificate shall have been exercised as provided in the
Warrant Agreement.

 

In the event of any inconsistency between
this warrant Certificate and the Warrant agreement, the terms of the Warrant Agreement shall govern.

 

THIS WARRANT CERTIFICATE SHALL BE CONSTRUED
AND ENFORCED IN ACCORDANCE WITH, AND THE RIGHTS OF THE COMPANY AND THE HOLDER HEREOF SHALL BE GOVERNED BY, THE INTERNAL LAWS OF
THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS RULES THEREOF TO THE EXTENT THAT ANY SUCH RULES WOULD REQUIRE
OR PERMIT THE APPLICATION OF THE LAWS OF ANY OTHER JURISDICTION, EXCEPT TO THE EXTENT THAT THE DELAWARE GENERAL CORPORATION LAW
SPECIFICALLY AND MANDATORILY APPLIES.

 

WITNESS the signature of a proper officer of the Company
as of the date first above written.

 

		TRINITY PLACE HOLDINGS INC.
		 
		By: 	             
		Name:
		Title:

 

    

     

    

 

[FORM OF ASSIGNMENT]

 

(To be executed by the registered holder
if

such holder desires to transfer the Warrant
Certificate)

 

FOR VALUE RECEIVED, ________________________ hereby sells,
assigns and transfers unto

 

 

(Please print name and address of transferee.)

 

the accompanying Warrant Certificate, together with all right,
title and interest therein, and does hereby irrevocably constitute and appoint:

 

 

 

attorney, to transfer the accompanying Warrant Certificate on
the books of the Company with full power of substitution.

 

Dated:                                   
, 20   .

 

		[HOLDER]
		 
		By: 	             
		Name:
		Title:

 

NOTICE

 

The signature to the foregoing Assignment must correspond to
the name as written upon the face of the accompanying Warrant Certificate or any prior assignment thereof in every particular,
without alteration or enlargement or any change whatsoever.

 

 

    	 

    	 

    

 

[FORM OF ELECTION TO PURCHASE]

 

(To be executed by the registered holder
if

such holder desires to exercise the Warrant
Certificate)

 

To: Trinity
Place Holdings Inc.

 

The undersigned hereby irrevocably elects to exercise _____________________
Denomination of Warrants represented by the accompanying Warrant Certificate to purchase the shares of Common Stock issuable upon
the exercise of such Warrants, and requests that certificates for such shares be issued in the name of:

 

(Please print name and address.)

 

_____________________________________________________________________________________________
(Please insert social security or other identifying number.)

 

If such Denomination of Warrants shall not be all the Warrants
evidenced by the accompanying Warrant Certificate, a new Warrant Certificate for the balance remaining of such Warrants shall be
registered in the name of the undersigned holder and delivered to:

 

(Please print name and address.)

 

_____________________________________________________________________________________________
(Please insert social security or other identifying number.)

 

The undersigned is paying the Exercise Price for the Common
Stock to be issued on exercise of the foregoing Warrants, unless payment of such Exercise Price has been waived by the Company,
by

 

   ̈
certified or bank check by wire transfer, or

   ̈
withholding of shares of Common Stock into which the Warrants are being exercised.

 

Dated:                                   
, 20     .

 

		[HOLDER]
		 
		By: 	             
		Name:
		Title:

 

NOTICE

 

The signature to the foregoing Election to Purchase must correspond
to the name as written upon the face of the accompanying Warrant Certificate or any prior assignment thereof in every particular,
without alteration or enlargement or any change whatsoever.

 

    

     

    

 

ANNEX 2-A

 

Address
for Purchaser for Notices

 

TPHS Lender LLC

520 Madison Avenue, 30th Floor

New York, New York 10022

 

With a copy (which shall not constitute notice) to:

 

Dechert LLP

1095 Avenue of the Americas

New York, New York 10036

Attention: Lindsay Flora & Adam Rosenthal

Email: Lindsay.Flora@dechert.com & Adam.Rosenthal@dechert.com

 

    

     

    

 

ANNEX 2-B

 

Address
of Company for Notices

 

Trinity Place Holdings Inc.

340 Madison Avenue

New York, New York 10173

Attention: Chief Executive Officer and Chief Financial Officer

Facsimile: 212-235-2199

 

With a copy (which shall not constitute notice) to:

 

Kramer Levin Naftalis & Frankel LLP

1177 Avenue of the Americas

New York, New York 10036

Attention: John Bessonette

Facsimile: 212-715-8000

Email: jbessonette@kramerlevin.comExhibit 10.3

 

EXECUTION
VERSION

 

REGISTRATION RIGHTS AGREEMENT

 

This REGISTRATION RIGHTS AGREEMENT (“Agreement”),
dated as of December 19, 2019, is made by and between Trinity Place Holdings Inc., a Delaware corporation (the “Company”)
and the investors set forth on Schedule A hereof (collectively, the “Investors” and each, an “Investor”).

 

W I T N E S S E T H

 

WHEREAS, the Company
has entered into that certain Warrant Agreement dated as of the date hereof (the “Warrant Agreement”) between
the Company and the Investors, pursuant to which the Company may from time to time be obligated to issue shares (the “Shares”)
of the Company’s common stock, par value $0.01 per share (the “Common Stock”) on the terms set forth therein;
and

 

WHEREAS, in connection with the Warrant Agreement,
the Company has agreed to provide registration rights to the Investors with respect to the Shares.

 

NOW, THEREFORE, in consideration
of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt of which is hereby
acknowledged, the parties agree as follows:

 

Article
I

 

Certain Definitions

 

For purposes of this
Agreement, the following terms shall have the following meanings:

 

(a)              
The term “Affiliate” means, with respect to any Person, any other Person directly or indirectly
controlling, controlled by, or under common control with, such Person; provided that, for the purposes of this definition,
“control” (including, with correlative meanings, the terms “controlled by” and “under common control
with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or
cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract
or otherwise.

 

(b)              
The term “Board” means the Board of Directors of the Company.

 

(c)              
The term “Commission” means the United States Securities and Exchange Commission or any successor
agency.

 

(d)              
The term “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.

 

(e)              
The term “Person” (but not “person”) means any individual, firm, corporation, partnership,
limited liability company, trust or other entity, and shall include any successor (by merger or otherwise) of such entity.

 

    1

     

    

 

(f)               
The term “Purchase Price” means $6.50 per Share.

 

(g)              
The term “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder.

 

Any terms used in this Agreement and not
defined herein shall have the meanings given such terms in the Warrant Agreement.

 

Article
II

 

Registration of Common Stock; Indemnification

 

Section 2.01     
Registrable Securities. For the purposes of this Agreement, “Registrable Securities” means the
Shares; provided that (i) any Shares of Common Stock will cease to be Registrable Securities, and (ii) the Company will
not be obligated to maintain the effectiveness of the Shelf Registration Statement (as defined below), and the Company’s
obligations under Section 2.02 hereof will cease, with respect to the Registrable Securities of a holder thereof (a “Holder”)
following the date on which (a) all such securities have been sold or otherwise transferred by the Holders thereof pursuant to
an effective registration statement; or (b) all such securities are sold in accordance with Rule 144 (or any successor provision)
promulgated under the Securities Act.

 

Section 2.02     
Registration. Within ninety (90) days following the date of the issuance of any Shares, the Company shall prepare
and file a resale registration statement on Form S-3 or another applicable form, if Form S-3 is not then available, registering
offers and sales of Registrable Securities held by the Investors and any Affiliated Purchasers pursuant to Rule 415 under the Securities
Act (such registration statement together with all exhibits thereto and any post-effective amendment thereto that becomes effective,
the “Shelf Registration Statement”). The Company may supplement the Shelf Registration Statement from time to
time to register securities other than Registrable Securities for sale for the account of any Person; provided, however,
that such supplement will be permitted only so long as the Commission rules provide that such supplement does not give the Commission
the right to review the Shelf Registration Statement; provided further that such supplement does not adversely affect the
rights of any Holder. Notwithstanding the foregoing or anything to the contrary in this Article II, if the Company grants registration
rights to one or more other holders of its Common Stock that are more favorable to such holders than the registration rights granted
hereunder, with respect to underwritten offerings or otherwise, the Company and holders of a majority of the Registrable Securities
hereunder shall in good faith amend this Agreement to reflect such more favorable terms as reasonably as practicable.

 

Section 2.03     
Registration Procedures. In connection with the registration of any Registrable Securities under the Securities Act
as provided in this Article II, the Company will use its best efforts to:

 

(a)               cause
the Shelf Registration Statement (and any other related registrations, qualifications or compliances as may be reasonably
requested and as would permit or facilitate the sale and distribution of all Registrable Securities until the
distribution thereof is complete) to become effective as soon as practicable following the filing thereof
(the “Scheduled Effective Date”);

 

    2

     

    

 

(b)              
prepare and file with the Commission the amendments and supplements to the Shelf Registration Statement and the Prospectus
(as defined below) used in connection therewith and take all other actions as may be necessary to keep the Shelf Registration Statement
continuously effective until the disposition of all securities in accordance with the intended methods of disposition by the Holder
or Holders thereof set forth in the Shelf Registration Statement is completed, and to comply with the provisions of the Securities
Act (to the extent applicable to the Company) with respect to the dispositions;

 

(c)              
(i) at least five (5) Business Days before filing with the Commission, furnish to each Holder and its counsel (if
any) copies of all documents proposed to be filed with the Commission in connection with such registration, which documents will
be subject to the review and reasonable comment of such Holder and its counsel; (ii) furnish to each Holder of Registrable Securities
a reasonable number of copies of the Shelf Registration Statement, of each amendment and supplement thereto, and of the Prospectus
included in the Shelf Registration Statement (including each preliminary prospectus), in conformity with the requirements of the
Securities Act, and the other documents (including exhibits to any of the foregoing), as the Holder may reasonably request, in
order to facilitate the disposition of the Registrable Securities owned by such Holder; (iii) respond as promptly as practicable
to any comments received from the Commission with respect to each Shelf Registration Statement or any amendment thereto and, as
promptly as reasonably possible; and (iv) provide the Holders true and complete copies of all correspondence from and to the Commission
relating to such Shelf Registration Statement that pertains to the Holders as “Selling Stockholders” but not any comments
that would result in the disclosure to the Holders of material and non-public information concerning the Company.

 

(d)              
register or qualify the Registrable Securities covered by the Shelf Registration Statement under the securities or
“blue sky” laws of the various states as any Holder reasonably requests and do any and all other acts and things that
may be necessary or reasonably advisable to enable a Holder to consummate the disposition in such states of the Registrable Securities
owned by such Holder, except that the Company will not be required to qualify generally to do business as a foreign corporation
in any jurisdiction wherein it would not, but for the requirements of this Section 2.03(d), be obligated to be qualified, or to
subject itself to taxation in any such jurisdiction;

 

(e)              
provide a transfer agent and registrar for the Registrable Securities covered by the Shelf Registration Statement
not later than the effective date of the Shelf Registration Statement;

 

    3

     

    

 

(f)                notify
the Holders promptly, and confirm such notice in writing, (i)(A) when a prospectus as contained in the Shelf Registration
Statement (a “Prospectus”) or any Prospectus supplement or post-effective amendment has been filed, and
(B) with respect to a Shelf Registration Statement or any post-effective amendment, when the same has become effective,
(ii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the
effectiveness of a Shelf Registration Statement or the initiation of any proceedings for that purpose, (iii) of the receipt
by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any
of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such
purpose, (iv) of the existence of any fact or the happening of any event that makes any statement made in such Shelf
Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by reference
untrue in any material respect or which requires the making of any changes in such Shelf Registration Statement, Prospectus
or documents so that, in the case of the Shelf Registration Statement, it will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not
misleading, and that in the case of the Prospectus, it will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein, in light of the
circumstances under which they were made, not misleading, (v) of the Company’s reasonable determination that a
post-effective amendment to a Shelf Registration Statement would be appropriate, or (vi) of any request by the Commission or
other governmental authority for amendments or supplements to a Shelf Registration Statement or related Prospectus or for
additional information that pertains to the Holders as “Selling Stockholders” or the “Plan of
Distribution”;

 

(g)              
enter into customary agreements (including, in the event the Holders elect to engage an underwriter in connection
with the Shelf Registration Statement, an underwriting agreement containing customary terms and conditions) and take all other
actions as may be reasonably required in order to expedite or facilitate the disposition of Registrable Securities; provided,
however, that the Company will not be liable for any underwriter’s fees, commissions and discounts or similar expenses;
and

 

(h)              
make every reasonable effort to obtain the withdrawal of any order suspending the effectiveness of the Shelf Registration
Statement or any suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction, at the earliest
possible time.

 

Section 2.04
      Rule 144. With a view to making available to the Holders the benefits of certain rules and regulations of the Commission
that at any time permit the sale of the Registrable Securities to the public without registration, the Company agrees to:

 

(a)              
make and keep public information available, as those terms are understood and defined in Rule 144 promulgated under
the Securities Act;

 

(b)              
file with the Commission in a timely manner all reports and other documents required of the Company under the Exchange
Act;

 

(c)               so
long as a Holder owns any unregistered Registrable Securities, furnish to the Holder upon any reasonable request a written
statement by the Company as to its compliance with the public information requirements of Rule 144 promulgated under the
Securities Act and/or the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and any
other reports and documents of the Company as the Holder may reasonably request in availing itself of any rule or regulation
of the Commission allowing a Holder to sell any Registrable Securities without registration (excluding any reports or
documents of the Company that the Company, in its sole discretion, deems confidential); and

 

    4

     

    

 

(d)              
take such further action as any Holder may reasonably request to enable such Holder to sell such Shares without registration
under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act, including
providing any legal opinions relating to such sale pursuant to Rule 144.

 

Section 2.05      Registration and Selling Expenses. All expenses incurred by the Company in connection with the Company’s performance
of or compliance with this Article II, including, without limitation, (i) all Commission registration and filing fees, (ii) blue
sky fees and expenses, (iii) all necessary printing and duplicating expenses, and (iv) all fees and disbursements of counsel and
accountants retained on behalf of the Company, will be paid by the Company. Each Holder may, at its election, retain its own counsel
and other representatives and advisors as it chooses at its own expense; provided that the Company will pay the reasonable
fees and expenses of one counsel to the Holders incurred as part of reviewing the Shelf Registration Statement and any Prospectuses
and amendments related thereto.

 

Section 2.06     
Registration Statement Not Declared Effective. The Company and the Holders agree that the Holders will suffer damages
if (i) a Shelf Registration Statement is not declared effective by the Commission on or prior to the Scheduled Effective Date,
or (ii) the length or frequency of Black-Out Periods (as defined below) exceed the limits set forth in Section 2.07(a) hereof.
The Company and the Holders further agree that it would not be feasible to ascertain the extent of such damages with precision.
Accordingly, (x) if the Shelf Registration Statement is not declared effective by the Commission on or prior to the Scheduled Effective
Date and on such date or at any time thereafter the Company is not diligently and in good faith making commercially reasonable
efforts to have the Shelf Registration Statement declared effective, the Company shall pay an amount in cash as liquidated damages
to each Holder equal to one percent (1%) of the Purchase Price of the Shares held by such Holder for each thirty (30) day period
after the Scheduled Effective Date during which the Company is failing to make such efforts, up to a maximum of four percent (4%);
and (y) during the continuance of a Black-Out Period beyond the limits set forth in Section 2.07(a) hereof, the Company shall pay
an amount in cash as liquidated damages to each Holder equal to one percent (1%) of the Purchase Price of the Shares held by such
Holder for each thirty (30) day period during the continuance of a Black-Out Period beyond such limits, pro-rated as applicable
for any partial month, up to a maximum of four percent (4%).

 

    5

     

    

 

Section 2.07     
Certain Obligations of Holders.

 

(a)               Each
Holder agrees that, upon receipt of any notice from the Company of (i) the happening of any event of the kind described in
Sections 2.03(f)(i)(A), 2.03(f)(ii), 2.03(f)(iii), 2.03(f)(iv), 2.03(f)(v) or 2.03(f)(vi) hereof, or (ii) a determination by
the Board that it is advisable to suspend use of the Prospectus for a discrete period of time due to pending corporate
developments such as negotiation of a material transaction which the Company in its sole discretion after consultation with
legal counsel, determines it would be obligated to disclose in the Shelf Registration Statement, which disclosure the Company
believes would be premature or otherwise inadvisable at such time or would have a material adverse effect on the Company and
its stockholders, such Holder will forthwith discontinue disposition of such Registrable Securities pursuant to the Shelf
Registration Statement or Prospectus until such Holder’s receipt of the copies of the supplemented or amended
Prospectus contemplated by Section 2.03(b) hereof, or until such Holder is advised in writing by the Company that the use of
the applicable Prospectus may be resumed and has received copies of any additional or supplemental filings that are
incorporated or deemed to be incorporated by reference in such Prospectus. The period of time in which the use of a
Prospectus or Shelf Registration Statement is so suspended shall be referred to as a “Black-Out Period.”
The Company agrees to so advise such Holder promptly of the commencement and termination of any such Black-Out Period, and
the Holders agree to keep the fact of such Black-Out Period confidential. The Company shall not impose a Black-Out Period
under this Section 2.07 for more than ninety (90) consecutive days and not more than twice in any given twelve (12) month
period; provided, that at least sixty (60) days must pass between Black-Out Periods and the total aggregate length of
all Black-Out Periods within any twelve (12) month period shall not exceed one hundred and twenty (120) days. Notwithstanding
the foregoing, the Company may suspend use of any Shelf Registration Statement if the Commission’s rules and
regulations prohibit the Company from maintaining the effectiveness of a Shelf Registration Statement because its
financial statements are stale at a time when its fiscal year has ended or it has made an acquisition reportable under Item
2.01 of Form 8-K or any other similar situation until the Company’s Form 10-K has been filed or a Form 8-K, including
any required pro forma or historical financial statements, has been filed, respectively (provided that the Company shall use
its reasonable best efforts to cure any such situation as soon as possible so that the Shelf Registration Statement can be
used at the earliest possible time).

 

(b)              
As a condition to the closing and to the inclusion of its Registrable Securities, each Holder will furnish to the
Company the information regarding the Holder as is legally required in connection with any registration, qualification or compliance
referred to in this Article II.

 

(c)              
Each Holder hereby covenants with the Company not to make any sale of the Registrable Securities pursuant to the
Shelf Registration Statement without effectively causing the prospectus delivery requirements under the Securities Act to be satisfied.

 

(d)              
Each Holder acknowledges and agrees that the Registrable Securities sold pursuant to the Shelf Registration Statement
are not transferable on the books of the Company unless the stock certificate submitted to the transfer agent evidencing the Registrable
Securities, if applicable, is accompanied by a certificate reasonably satisfactory to the Company to the effect that (i) the Registrable
Securities have been sold in accordance with this Agreement and the Shelf Registration Statement and (ii) the requirement of delivering
a current prospectus has been satisfied.

 

(e)              
Each Holder is hereby advised that the anti-manipulation provisions of Regulation M under the Exchange Act may apply
to sales of the Registrable Securities offered pursuant to the Shelf Registration Statement and agrees not to take any action with
respect to any distribution deemed to be made pursuant to the Shelf Registration Statement that constitutes a violation of Regulation
M under the Exchange Act or any other applicable rule, regulation or law.

 

    6

     

    

 

(f)               
The rights to cause the Company to register Registrable Securities granted to the Holders by the Company under Section
2.02 hereof may be assigned in whole or in part by a Holder in connection with the transfer of such Registrable Securities; provided,
that: (i) the transfer of the Registrable Securities and the rights to register such Registrable Securities are effected in accordance
with applicable securities laws, (ii) the transfer involves not less than fifty percent (50%) of the Shares, (iii) the Holder gives
prior written notice to the Company, and (iv) the transferee agrees to comply with the terms and provisions of this Agreement
in a written instrument reasonably satisfactory in form and substance to the Company and its counsel. Except as specifically permitted
by this Section 2.07, the rights of a Holder with respect to Registrable Securities will not be transferable to any other Person,
and any attempted transfer will cause all rights of the Holder to registration of Registrable Securities under this Article II
to be forfeited, void ab initio and of no further force and effect.

 

(g)              
With the written consent of the Company and each Holder affected or potentially affected by such proposed waiver,
any provision of Sections 2.01, 2.02, 2.03, 2.04, 2.05, 2.06, 2.07 or 2.08 hereof may be waived (either generally or in a particular
instance, either retroactively or prospectively and either for a specified period of time or indefinitely). Upon the effectuation
of each waiver, the Company will promptly give written notice thereof to such Holders.

 

(h)              
If any Warrants (as defined in the Warrant Agreement) are transferred pursuant to the terms thereof, the transferee
shall be deemed an Investor for all purpose hereunder. The Company and the applicable transferee shall execute a joinder to this
Agreement whereupon the transferee agrees to be bound by the terms and obligations set forth herein.

 

Section 2.08      Indemnification.

 

(a)               By
the Company. The Company agrees to indemnify, to the fullest extent permitted by law, each Holder of
Registrable Securities being sold, its directors, officers, employees, members, managers, partners, agents, and each other
Person, if any, who controls (within the meaning of the Securities Act and the rules and regulations thereunder) such Holder
(each, an “Indemnified Person”) against all losses, claims, damages, liabilities, and expenses (including
legal fees and expenses and all costs incident to investigation or preparation with respect to such losses, claims, damages,
liabilities, and expenses and to reimburse such Indemnified Person for such costs as incurred) (collectively, the
“Losses”) caused by, resulting from, or relating to any untrue or alleged untrue statement of material
fact contained in the Shelf Registration Statement, Prospectus, or preliminary prospectus or any amendment thereof or
supplement thereto or any omission or alleged omission of a material fact required to be stated therein or a fact necessary
to make the statements therein not misleading, except insofar as the same are caused by or contained in any information
furnished to the Company by or on behalf of such Holder in writing expressly for use therein or by such Holder’s
failure to deliver a copy of the Shelf Registration Statement or Prospectus or any amendments or supplements thereto after
the Company has furnished such Holder with a sufficient number of copies of the same and notified such Holder of such
obligation. In connection with an underwritten offering and without limiting any of the Company’s other obligations
under this Agreement, the Company shall indemnify such underwriters, their officers, directors, employees, and agents and
each Person who controls (within the meaning of the Securities Act and the rules and regulations thereunder) such
underwriters or such other Indemnified Person to the same extent as provided above with respect to the indemnification of the
Holders of Registrable Securities being sold.

 

    7

     

    

 

(b)              
By the Investors. In connection with any registration statement in which a Holder of Registrable Securities
is participating pursuant to this Agreement, each such Holder will, if requested, furnish to the Company in writing information
regarding such Holder’s ownership of Registrable Securities and, to the extent permitted by law, shall, severally and not
jointly, indemnify the Company, its directors, and each Person who controls (within the meaning of the Securities Act and the rules
and regulations thereunder) the Company against all Losses caused by, resulting from, or relating to any untrue or alleged untrue
statement of material fact contained in the Shelf Registration Statement, Prospectus, or preliminary prospectus or any amendment
thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein not misleading, but only to the extent that such untrue statement or omission is caused by and contained
in such information so furnished to the Company in writing by or on behalf of such Holder expressly for use therein; provided,
however, that each Holder’s obligation to indemnify the Company hereunder shall be apportioned between each Holder
based upon the net amount received by each Holder from the sale of Registrable Securities, as compared to the total net amount
received by all of the Holders of Registrable Securities sold pursuant to such registration statement, no such Holder being liable
to the Company in excess of such apportionment; and provided further that each Holder’s obligation to indemnify the
Company hereunder shall be apportioned between each Holder as is appropriate to reflect the relative fault of such Holder on the
one hand, and of each other Holder on the other, in connection with the statements or omissions that resulted in such Losses. The
relative fault of each Holder on the one hand, and each other Holder on the other, shall be determined by reference to, among other
things, whether any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by such Holder and the parties’ relevant intent, knowledge, information and opportunity
to correct or prevent such statement or omission.

 

(c)              
Notice. Any Person entitled to indemnification hereunder shall give prompt written notice to the indemnifying
party of any claim with respect to which its seeks indemnification; provided, however, that the failure to give such
notice shall not release the indemnifying party from its obligation, except to the extent that the indemnifying party has been
materially prejudiced by such failure to provide such notice.

 

    8

     

    

 

(d)               Defense
of Actions. In any case in which any such action is brought against any indemnified party and it notifies an indemnifying
party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it
may wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel
reasonably satisfactory to such indemnified party, and, after notice from the indemnifying party to such indemnified party of
its election so to assume the defense thereof, the indemnifying party will not (so long as it shall continue to have the
right to defend, contest, litigate, and settle the matter in question in accordance with this paragraph) be liable to such
indemnified party hereunder for any legal or other expense subsequently incurred by such indemnified party in connection with
the defense thereof other than reasonable costs of investigation, supervision, and monitoring (unless such indemnified party
reasonably objects to such assumption on the grounds that there may be defenses available to it that are different from or in
addition to the defenses available to such indemnifying party or if a conflict or potential conflict of interest exists, in
either of which event the indemnified party shall be reimbursed by the indemnifying party for the expenses incurred in
connection with retaining separate legal counsel). An indemnifying party shall not be liable for any settlement of an action
or claim effected without its consent, which consent shall not be unreasonably withheld, conditioned or delayed. The
indemnifying party shall lose its right to defend, contest, litigate, and settle a matter if it shall fail diligently to
contest such matter (except to the extent settled in accordance with the next following sentence). No matter shall be settled
by an indemnifying party without the consent of the indemnified party (which consent shall not be unreasonably withheld,
conditioned or delayed). The indemnifying party shall not, without the prior written consent of an indemnified party (which
consent shall not be unreasonably withheld, conditioned or delayed), effect any settlement of any pending or threatened
proceedings in respect of which indemnity has been sought hereunder by such indemnified party unless (i) such settlement
includes an unconditional release of such indemnified party in form and substance satisfactory to such indemnified party from
all liability on the claims that are the subject matter of such proceedings and (ii) such settlement does not include any
statement as to or any admission of fault, culpability or a failure to act by or on behalf of any indemnified party.

 

(e)              
Jointly Indemnifiable Claims. Given that an Indemnified Person may be entitled to indemnification (a “Jointly
Indemnifiable Claim”) from both the Company, pursuant to this Agreement, and from any other Person, whether pursuant
to applicable law, any indemnification agreement, the organizational documents of such Person or otherwise (the “Indemnitee-Related
Entities”), the Company acknowledges and agrees that the Company shall be fully and primarily responsible for the payment
to the Indemnified Person in respect of indemnification and advancement of expenses in connection with any such Jointly Indemnifiable
Claim, pursuant to and in accordance with the terms of this Agreement, irrespective of any right of recovery the Indemnified Person
may have from the Indemnitee-Related Entities. Under no circumstance shall the Company be entitled to any right of subrogation
or contribution by the Indemnitee-Related Entities and no right of recovery the Indemnified Person may have from the Indemnitee-Related
Entities shall reduce or otherwise alter the rights of the Indemnified Person or the obligations of the Company hereunder. In the
event that any of the Indemnitee-Related Entities shall make any payment to the Indemnified Person in respect of indemnification
or advancement of expenses with respect to any Jointly Indemnifiable Claim, the Indemnitee-Related Entity making such payment shall
be subrogated to the extent of such payment to all of the rights of recovery of the Indemnified Person against the Company, and
the Indemnified Person shall execute all papers reasonably required and shall do all things that may be reasonably necessary to
secure such rights, including the execution of such documents as may be necessary to enable the Indemnitee-Related Entities effectively
to bring suit to enforce such rights. Each of the Indemnitee-Related Entities shall be third-party beneficiaries with respect to
this Section 2.08(e), entitled to enforce this Section 2.08(e) against the Company as though each such Indemnitee-Related Entity
were a party to this Agreement.

 

(f)               
Survival. The indemnification provided for under this Agreement shall remain in full force and effect regardless
of any investigation made by or on behalf of the Indemnified Person and will survive the transfer of the Registrable Securities
and the termination of this Agreement.

 

    9

     

    

 

(g)              
Contribution. If recovery is not available under the foregoing indemnification provisions for any reason or
reasons other than as specified therein, any Person who would otherwise be entitled to indemnification by the terms thereof shall
nevertheless be entitled to contribution with respect to any Losses with respect to which such Person would be entitled to such
indemnification but for such reason or reasons. In determining the amount of contribution to which the respective Persons are entitled,
there shall be considered the Persons’ relative knowledge and access to information concerning the matter with respect to
which the claim was asserted, the opportunity to correct and prevent any statement or omission, and other equitable considerations
appropriate under the circumstances, including the relative fault of such Person, in connection with the statements or omissions
that resulted in Losses. The relative fault of each Person shall be determined by reference to, among other things, whether any
untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates
to information supplied by such Person and the parties’ relevant intent, knowledge, information and opportunity to correct
or prevent such statement or omission. It is hereby agreed that it would not necessarily be equitable if the amount of such contribution
were determined by pro rata or per capita allocation. No Person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. Notwithstanding the foregoing, the Investors and any Affiliate of such Investors shall not be required to make
a contribution in excess of (i) the net amount received by such Investors (or their respective Affiliates) from the sale of Registrable
Securities.

 

Article
III

 

Miscellaneous

 

Section
3.01      Inconsistent Agreements.  Without the prior written consent of the Investors, the Company shall not enter into
any registration rights agreement that conflicts, or is inconsistent, with the provisions of Article II hereof.

 

Section
3.02      Specific Performance. Each of the Investors and the Company acknowledge and agree that, in the event of any
breach of this Agreement, the non-breaching party or parties would be irreparably harmed and could not be made whole by monetary
damages. The Investors and the Company hereby agree that, in addition to any other remedy to which the Investors may be entitled
at law or in equity, the Investors shall be entitled to compel specific performance of this Agreement in any action instituted
in any court of the United States or any state thereof having subject matter jurisdiction for such action.

 

Section
3.03      Headings. The headings in this Agreement are for convenience of reference only and shall not control or affect
the meaning or construction of any provisions hereof.

 

Section
3.04      Entire Agreement. Except for the Warrant Agreement, this Agreement (a)
constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter contained herein,
and there are no restrictions, promises, representations, warranties, covenants, conditions, or undertakings with respect to
the subject matter hereof, other than those expressly set forth or referred to herein, and (b) amends and supersedes all
prior agreements and understandings between the parties hereto with respect to the subject matter hereof.

 

    10

     

    

 

Section
3.05     Notices. All notices and other communications hereunder shall be in writing and shall be delivered personally,
by next-day courier, by electronic or facsimile transmission, or telecopied with confirmation of receipt to the parties at the
addresses specified below (or at such other address for a party as shall be specified by like notice; provided that notices
of change of address shall be effective only upon receipt thereof). Any such notice shall be effective upon receipt, if personally
delivered, delivered by electronic or facsimile transmission, or telecopied, or one day after delivery to a courier for next-day
delivery.

 

If to the Company, to:

 

Trinity Place Holdings Inc.

340 Madison Avenue

New York, New York 10173

Attention: Chief Executive Officer and Chief Financial Officer

Email: matt.messinger@tphs.com and
steven.kahn@tphs.com

 

with a copy (which shall not constitute notice) to:

 

Kramer Levin Naftalis & Frankel LLP

1177 Avenue of the Americas

New York, NY 10036

Attention: John Bessonette

Email: jbessonette@kramerlevin.com

 

If to the Investors or the Holder(s), to:

 

The names and addresses on Schedule A,
or at such other address as such Investor or Holder shall have specified to the Company in writing.

 

Section
3.06     Governing Law; Venue. THIS AGREEMENT WILL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS
OF THE STATE OF NEW YORK. EACH HOLDER HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF, AND VENUE IN, THE UNITED STATES
COURT FOR THE SOUTHERN DISTRICT OF NEW YORK AND WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS. EACH PARTY ACKNOWLEDGES
AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES,
AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY
IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR THE BREACH, TERMINATION
OR VALIDITY OF THIS AGREEMENT, OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT
(A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY
WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH SUCH PARTY UNDERSTANDS AND HAS
CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH SUCH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D) EACH SUCH PARTY HAS
BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION
3.06.

 

    11

     

    

 

Section
3.07     Severability. The invalidity, illegality, or unenforceability of one or more of the
provisions of this Agreement in any jurisdiction shall not affect the validity, legality, or enforceability of the remainder of
this Agreement in such jurisdiction or the validity, legality, or enforceability of this Agreement, including any such provision,
in any other jurisdiction, it being intended that all rights and obligations of the parties hereunder shall be enforceable to
the fullest extent permitted by law.

 

Section
3.08     Successors; Assigns. The provisions of this Agreement shall be binding upon the parties hereto and their respective
heirs, successors, and permitted assigns, including, without limitation and without the need for an express assignment or assumption,
any successor in interest to an Investor, whether by a sale of all or substantially all of its assets, merger, consolidation, or
otherwise. Neither this Agreement nor the rights or obligations of any party hereunder may be assigned, except as otherwise provided
in this Agreement. Any such attempted assignment in contravention of this Agreement shall be void and of no effect.

 

Section
3.09      No Third-Party Beneficiaries. Nothing in this Agreement creates in any Person not a party to this Agreement
(other than permitted assignees and a Person indemnified pursuant to Section 2.08 hereof with respect to such indemnification rights
and any Holders of the Registrable Securities with respect to the rights to which they are entitled hereunder) any legal or equitable
right, remedy or claim under this Agreement, and this Agreement is for the exclusive benefit of the parties hereto.

 

Section
3.10      Amendments. This Agreement may not be amended, modified, or supplemented unless such modification is in writing
and signed by the Company and each Investor.

 

Section
3.11      Waiver. Any waiver (express or implied) of any default or breach of this Agreement shall not constitute a waiver
of any other or subsequent default or breach.

 

Section
3.12      Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original
but all of which shall constitute one and the same Agreement and will become effective when counterparts have been signed by each
of the parties and delivered to the other party (including via facsimile or other electronic transmission), it being understood
that each party need not sign the same counterpart.

 

[SIGNATURE PAGE FOLLOWS]

 

    

     

    

 

IN WITNESS WHEREOF, the
undersigned hereby agree to be bound by the terms and provisions of this Registration Rights Agreement as of the date first above
written.

 

	
         

         
	TRINITY PLACE HOLDINGS INC.
	 	 
	 	By:	/s/ Steven Kahn
	 	Name:  Steven Kahn
	 	Title:    Chief Financial Officer 

 

[Signature Page to Registration Rights Agreement]

 

    

     

    

 

	 	TPHS LENDER LLC
	 	 
	 	By:	/s/ Joshua D. Morris
	 	Name: Joshua D. Morris
	 	Title:   Manager 

 

[Signature Page to Registration Rights Agreement]

 

    

     

    

 

Schedule A

 

	Name of Investor	
        Address

         

	TPHS Lender LLC	
        520 Madison Avenue, 30th Floor

        New York, New York 10022

         

        with a copy (which shall not constitute notice) to:

         

        Dechert LLP

        1095 Avenue of the Americas

        New York, New York 10036

        Attention: Lindsay Flora & Adam Rosenthal

        Email: Lindsay.Flora@dechert.com & 

Adam.Rosenthal@dechert.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]